Scientific article

Controversies in Drug Allergy: Beta-Lactam Hypersensitivity Testing

Publication date2019

All beta-lactam use is associated with a certain rate of adverse reactions. Many of these adverse reactions result in an allergy to the beta-lactam being entered into the patient's medical record. Unfortunately, only a small minority of these recorded allergies are clinically significant immunologically mediated drug hypersensitivity. An unconfirmed allergy to beta-lactams is a significant public health risk, because patients so labeled typically do not receive narrow-spectrum penicillins and cephalosporins when clinically indicated. The alternative antibiotics they receive result in poorer clinical outcomes, increased incidence of serious antibiotic-resistant infections, prolonged hospitalizations, and greater health care utilization. There is a wide variation in beta-lactam allergy incidence and prevalence around the world, based in part on the specific beta-lactams used and overused. There is a wide variation in specific protocols used to confirm current tolerance of beta-lactams and remove these inaccurate allergy reports. Harmonizing testing protocols, when possible, may lead to more widespread use of narrow-spectrum beta-lactams, when clinically indicated, and improve patient safety worldwide. Further research is needed to better understand the regional differences in reporting beta-lactam allergy as this relates to regional differences in beta-lactam use and overuse, the frequency of clinically significant immunologically mediated beta-lactam hypersensitivity, and the optimal testing strategies to confirm current tolerance, based on presenting clinical symptoms.

  • Allergy
  • Beta-lactam
  • Cephalosporin
  • Challenge
  • Drug provocation test
  • Hypersensitivity
  • IgE
  • Penicillin
  • Skin
  • Test
  • Severe cutaneous adverse reaction
  • T cell
Citation (ISO format)
TORRES, Maria J et al. Controversies in Drug Allergy: Beta-Lactam Hypersensitivity Testing. In: The Journal of Allergy and Clinical Immunology: In Practice, 2019, vol. 7, n° 1, p. 40–45. doi: 10.1016/j.jaip.2018.07.051
Main files (1)
Article (Published version)
ISSN of the journal2213-2201

Technical informations

Creation11/04/2019 2:23:00 PM
First validation11/04/2019 2:23:00 PM
Update time03/15/2023 10:01:24 PM
Status update03/15/2023 10:01:23 PM
Last indexation01/17/2024 9:57:34 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack